Incyte
INCY
#1220
Rank
S$23.53 B
Marketcap
S$118.24
Share price
-2.10%
Change (1 day)
43.36%
Change (1 year)

Earnings for Incyte (INCY)

Earnings in 2024: S$0.40 Billion

According to Incyte's latest financial reports the company's current earnings are S$4.81 Billion. In 2024 the company made an earning of S$0.40 Billion a decrease over its 2023 earnings that were of S$1.06 Billion. The earnings displayed on this page are the earnings before interest and taxes or simply EBIT.

Earnings history for Incyte from 1994 to 2024

Annual earnings

Year Earnings Change
2024S$0.40 B-62.04%
2023S$1.06 B57.66%
2022S$0.67 B-7.24%
2021S$0.73 B-345.65%
2020-S$0.3 Billion-147.7%
2019S$0.62 B322.02%
2018S$0.14 B-136.94%
2017-S$0.41 Billion-390.76%
2016S$0.13 B1322%
2015S$9.68 M-115.56%
2014-S$62.24 Million-41.4%
2013-S$0.11 Billion87.67%
2012-S$56.6 Million-74.9%
2011-S$0.23 Billion843.59%
2010-S$23.89 Million-88.68%
2009-S$0.22 Billion1.37%
2008-S$0.21 Billion86.16%
2007-S$0.12 Billion17.64%
2006-S$95.08 Million-28.62%
2005-S$0.14 Billion-36.1%
2004-S$0.21 Billion-2.03%
2003-S$0.22 Billion22.26%
2002-S$0.18 Billion-27.39%
2001-S$0.24 Billion198.72%
2000-S$80.24 Million132.2%
1999-S$34.56 Million-556.86%
1998S$7.56 M-37.23%
1997S$12.05 M-259.32%
1996-S$7.57 Million-45.87%
1995-S$13.98 Million-9.17%
1994-S$15.39 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Novartis
NVS
S$20.96 B 929.57%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Pfizer
PFE
S$15.19 B 646.24%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
S$28.84 B 1,316.90%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
S$10.56 B 419.07%๐Ÿ‡บ๐Ÿ‡ธ USA
Ligand Pharmaceuticals
LGND
S$85.62 M-95.79%๐Ÿ‡บ๐Ÿ‡ธ USA
Geron
GERN
-S$58.88 Million-102.89%๐Ÿ‡บ๐Ÿ‡ธ USA
CTI BioPharma
CTIC
-S$88.76 Million-104.36%๐Ÿ‡บ๐Ÿ‡ธ USA
AVEO Oncology
AVEO
-S$37.23 Million-101.83%๐Ÿ‡บ๐Ÿ‡ธ USA
Ardelyx
ARDX
-S$71.22 Million-103.50%๐Ÿ‡บ๐Ÿ‡ธ USA